Literature DB >> 22231083

Foundation medicine.

Michael Eisenstein.   

Abstract

Mesh：

Year:  2012        PMID： 22231083     DOI： 10.1038/nbt0112-14

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  1 in total

1.  Myriad decision reassures biotechs but diagnostics still murky.

Authors:  Malorye Allison
Journal:  Nat Biotechnol       Date:  2011-09-08       Impact factor: 54.908
  1 in total
  4 in total

Review 1.  Advances in the Molecular Analysis of Soft Tissue Tumors and Clinical Implications.

Authors:  Adrian Marino-Enriquez
Journal:  Surg Pathol Clin       Date:  2015-09

2.  Roche spends $1 billion on Foundation Medicine's tumor profiling.

Authors:  Mark Ratner
Journal:  Nat Biotechnol       Date:  2015-03       Impact factor: 54.908

Review 3.  Prospects on strategies for therapeutically targeting oncogenic regulatory factors by small-molecule agents.

Authors:  Chih-Chien Chou; Santosh B Salunke; Samuel K Kulp; Ching-Shih Chen
Journal:  J Cell Biochem       Date:  2014-04       Impact factor: 4.429

4.  Global connectivity of hub residues in Oncoprotein structures encodes genetic factors dictating personalized drug response to targeted Cancer therapy.

Authors:  Venky Soundararajan; Murali Aravamudan
Journal:  Sci Rep       Date:  2014-12-03       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.